HEAVENLYDOOR COM INC
4, 2000-07-10
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: MATRITECH INC/DE/, 8-K, EX-4.1, 2000-07-10
Next: BIOVAIL CORPORATION INTERNATIONAL, POS AM, 2000-07-10




                     U.S. SECURITIES AND EXCHANGE COMMISSION
                              Washington, DC 20549

                                     FORM 4

                  STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934,
       Section 17(a) of the Public Utility Holding Company Act of 1935 or
               Section 30(f) of the Investment Company Act of 1940

|_|   Check this box if no longer subject to Section 16. Form 4 or Form 5
      obligations may continue. See Instruction 1(b).

================================================================================
1. Name and Address of Reporting Person*

   Rosenwald, M.D.       Lindsay                 A.
--------------------------------------------------------------------------------
   (Last)               (First)                 (Middle)

   c/o Paramount Capital Asset Management, Inc.
   787 Seventh Avenue, 48th Floor
--------------------------------------------------------------------------------
                                    (Street)


   New York              NY                      10019
--------------------------------------------------------------------------------
   (City)               (State)                 (Zip)


================================================================================
2. Issuer Name and Ticker or Trading Symbol

   Heavenly Door Corporation (HVDC)
================================================================================
3. IRS Identification Number of Reporting Person, if an Entity (Voluntary)


================================================================================
4. Statement for Month/Year

   June 2000
================================================================================
5. If Amendment, Date of Original (Month/Year)


================================================================================
6. Relationship of Reporting Person to Issuer
   (Check all applicable)

   |_|   Director                             |X|   10% Owner
   |_|   Officer (give title below)           |_|   Other (specify below)


================================================================================
7. Individual or Joint/Group Filing (Check Applicable Line)

   |_|  Form filed by one Reporting Person
   |X|  Form filed by more than one Reporting Person

================================================================================

* If the Form is filed by more than one Reporting Person, see Instruction
  4(b)(v).
<PAGE>

================================================================================
           Table I -- Non-Derivative Securities Acquired, Disposed of,
                             or Beneficially Owned
================================================================================
<TABLE>
<CAPTION>
                                                                                                     6.
                                                      4.                              5.             Owner-
                                                      Securities Acquired (A) or      Amount of      ship
                                         3.           Disposed of (D)                 Securities     Form:     7.
                                         Transaction  (Instr. 3, 4 and 5)             Beneficially   Direct    Nature of
                           2.            Code         ----------------------------    Owned at End   (D) or    Indirect
1.                         Transaction   (Instr. 8)                   (A)             of Month       Indirect  Beneficial
Title of Security          Date          ------------     Amount      or     Price    (Instr. 3      (I)       Ownership
(Instr. 3)                 (mm/dd/yy)     Code     V                  (D)             and 4)         (Instr.4) (Instr. 4)
------------------------------------------------------------------------------------------------------------------------------------
<S>                        <C>            <C>      <C>    <C>         <C>    <C>       <C>           <C>       <C>
                                                                                                               By The Aries Master
Common Stock               6/13/00        P               3,029       A      $1.063    16,498,372(1) I         Fund II(2)
------------------------------------------------------------------------------------------------------------------------------------
Common Stock               06/13/00       P               1,584       A      $1.063    16,498,372(1) I         By Aries Domestic
                                                                                                               Fund, L.P.(2)
------------------------------------------------------------------------------------------------------------------------------------
Common Stock               06/13/00       P                 387       A      $1.063    16,498,372(1) I         By Aries Domestic
                                                                                                               Fund II, L.P.(2)
====================================================================================================================================
</TABLE>

Reminder: Report on a separate line for each class of securities beneficially
owned directly or indirectly.


                                   Page 1 of 3
<PAGE>

FORM 4 (continued)

Table II -- Derivative Securities Acquired, Disposed of, or Beneficially Owned
            (e.g., puts, calls, warrants, options, convertible securities)

================================================================================
<TABLE>
<CAPTION>
                                                                                                          9.        10.
                                                                                                          Number    Owner-
                                                                                                          of        ship
                    2.                                                                                    Deriv-    Form of
                    Conver-                    5.                              7.                         ative     Deriv-   11.
                    sion                       Number of                       Title and Amount           Secur-    ative    Nature
                    of                         Derivative    6.                of Underlying     8.       ities     Secur-   of
                    Exer-             4.       Securities    Date              Securities        Price    Bene-     ity:     In-
                    cise     3.       Trans-   Acquired (A)  Exercisable and   (Instr. 3 and 4)  of       ficially  Direct   direct
                    Price    Trans-   action   or Disposed   Expiration Date   ----------------  Deriv-   Owned     (D) or   Bene-
1.                  of       action   Code     of(D)         (Month/Day/Year)            Amount  ative    at End    In-      ficial
Title of            Deriv-   Date     (Instr.  (Instr. 3,    ----------------            or      Secur-   of        direct   Owner-
Derivative          ative    (Month/  8)       4 and 5)      Date     Expira-            Number  ity      Month     (I)      ship
Security            Secur-   Day/     ------   ------------  Exer-    tion               of      (Instr.  (Instr.   (Instr.  (Instr.
(Instr. 3)          ity      Year)    Code V    (A)   (D)    cisable  Date     Title     Shares  5)       4)        4)       4)
------------------------------------------------------------------------------------------------------------------------------------
<S>                 <C>      <C>      <C>  <C>  <C>   <C>    <C>      <C>      <C>       <C>     <C>      <C>       <C>      <C>
N/A
====================================================================================================================================
</TABLE>
Explanation of Responses:

(1)   See Attachment A

*     Paramount Capital Asset Management, Inc. ("PCAM") is the general partner
      of each of the Aries Domestic Fund, L.P. ("Aries I") and Aries Domestic
      Fund II, L.P. ("Aries II"), each a Delaware limited partnership, and also
      serves as the investment manager of The Aries Master Fund II, a Cayman
      Island exempted company (the "Master Fund"), which also owns securities of
      the Issuer. Dr. Rosenwald is the chairman and sole stockholder of PCAM. As
      a result, Dr. Rosenwald and PCAM may be deemed to have voting and
      investment control over the securities of the issuer owned by the Aries
      Funds under Rule 16a-(a)(1) of the Securities Exchange Act of 1934. Dr.
      Rosenwald and PCAM disclaim beneficial ownership of the securities held by
      the Aries Funds, except to the extent of its pecuniary interest therein,
      if any.

**  Intentional misstatements or omissions of facts constitute Federal Criminal
    Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).


/s/ Lindsay A. Rosenwald                                      July 10, 2000
---------------------------------------------            -----------------------
** Signature of Reporting Person                                  Date
   Lindsay A. Rosenwald, M.D.
   Chairman
   Paramount Capital Asset Management, Inc.
   General Partner

Note: File three copies of this Form, one of which must be manually signed. If
      space provided is insufficient, see Instruction 6 for procedure.


                                   Page 2 of 3
<PAGE>

                                  ATTACHMENT A

Securities beneficially owned by Dr. Rosenwald are presented on an as-converted
basis and consist of the following:

1.    401,238 shares of common stock of the Issuer, par value $0.01 per share
      (the "Common Stock") and (i) 1,801,278 shares of Common Stock, (ii) Class
      C Warrants exercisable for 425,069 shares of Common Stock and (iii) Class
      A Warrants exercisable for 112,391 shares of Common Stock, underlying Unit
      Purchase Options owned directly by Dr. Rosenwald.

2.    7,659,501 shares of Common Stock; Line of Credit Warrants (the "LOC
      Warrants") exercisable for 124,847 shares of Common Stock; Class A
      Warrants exercisable for 117,757 shares of Common Stock; Class C Warrants
      exercisable for 495,442 shares of Common Stock; Class D Warrants
      exercisable for 441,000 shares of Common Stock; and (i) 203,848 shares of
      Common Stock, (ii) Class C Warrants exercisable for 51,067 shares of
      Common Stock, and (iii) Class A Warrants exercisable for 12,456 shares of
      Common Stock underlying Unit Purchase Options owned directly by The Aries
      Master Fund II, a Cayman Islands entity.

3.    3,856,607 shares of Common Stock; Line of Credit Warrants (the "LOC
      Warrants") exercisable for 124,847 shares of Common Stock; Class A
      Warrants exercisable for 73,871 shares of Common Stock; Class C Warrants
      exercisable for 258,136 shares of Common Stock; Class D Warrants
      exercisable for 189,000 shares of Common Stock; and (i) 103,813 shares of
      Common Stock, (ii) Class C Warrants exercisable for 25,153 shares of
      Common Stock, and (iii) Class A Warrants exercisable for 8,056 shares of
      Common Stock underlying Unit Purchase Options owned directly by Aries
      Domestic Fund, L.P., a Delaware limited partnership.

4.    12,995 shares of Common Stock owned directly by Aries Domestic Fund II,
      L.P., a Delaware limited partnership.


                                   Page 3 of 3



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission